• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

ERBI and London Biotechnology Network to Merge


May 7, 2010.


(Cambridge, UK), a not-for-profit membership organization for international life science and healthcare companies, and the

London Biotechnology Network

(LBN), a business network for London-based life science organizations, are to merge. The combined group will operate under the ERBI name, until the launch of a new identity at the ERBI Annual Conference on 2nd June.

The new organization combines ERBI’s 350+ members with LBN’s network of over 400 organizations across a wide range of life science industry sectors. The merger will mean that members have access to a significantly larger pool of companies to support business-to-business interaction, as well as an expanded training programme focused on the needs of life science companies. ERBI’s Harriet Fear becomes CEO of the merged companies; LBN leader Tony Jones becomes Director, Business Development, and a member of the senior management team.